The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association
Abstract
The association of high levels of autoantibodies to glutamic acid decarboxylase (GAD-ab) and stiff-person syndrome (SPS) is well known. However, the full spectrum of neurological syndromes associated with GAD-ab is not well established. In addition, these patients usually present type 1 diabetes mellitus (DM1) that could justify the presence of high GAD-ab levels. To clarify these issues, we reviewed the clinical and immunological features of patients in whom high GAD-ab levels were detected in a reference centre for DM1 and for the detection of antineuronal antibodies in suspected paraneoplastic neurological syndromes (PNS). High GAD-ab levels were defined as values > or =2000 U/ml by radioimmunoassay. Intrathecal synthesis (IS) of GAD-ab was calculated in paired serum/CSF samples. Values higher than the IgG index were considered indicators for positive GAD-ab-specific IS. High GAD-ab levels were identified in 61 patients, 22 (36%) had SPS, 17 (28%) cerebellar ataxia, 11 (18%) other neurological disorders (epilepsy -- four, PNS -- four; idiopathic limbic encephalitis -- two; myasthenia gravis -- one), and 11 (18%) isolated DM1. Patients with SPS and cerebellar ataxia had the same frequency of female gender (86% vs 94%), DM1 (59% vs 53%), CSF oligoclonal bands (35% vs 69%). Three of the four PNS patients, with paraneoplastic encephalomyelitis, a predominant gait cerebellar ataxia, and limbic encephalitis, had neuroendocrine carcinomas. GAD expression was confirmed in the two tumours in which the study was done. The fourth patient presented with paraneoplastic cerebellar degeneration antedating a lung adenocarcinoma. The frequency of increased IS of GAD-ab was 85% in SPS, 100% in cerebellar ataxia, and 86% in other neurological disorders. In conclusion, our study emphasizes that high GAD-ab levels associate with other neurological disorders besides SPS. Cerebellar ataxia, the second most common syndrome associated with high GAD-ab levels, shares with SPS the same demographic, clinical and immunological features. The demonstration of an increased IS of GAD-ab is important to confirm that the GAD autoimmunity is related to the neurological syndrome particularly when there is a concomitant DM1 that could justify the presence of high GAD-ab levels. Lastly, in patients who develop neurological syndromes that suggest a PNS, the finding of GAD-ab does not rule out this possibility and appropriate studies should be done to confirm an underlying cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034447 · Cited by 1,610
Self-citationGultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man Syndrome
Solimena, M., Folli, F., Aparisi, R., Pozza, G., & De Camilli, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222202 · Cited by 629
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 488
Amphiphysin autoimmunity: Paraneoplastic accompaniments
Pittock, S. J., Lucchinetti, C. F., Parisi, J. E., Benarroch, E. E., Mokri, B., Stephan, C. L., Kim, K., Kilimann, M. W., & Lennon, V. A. (2005) · Annals of Neurology · doi:10.1002/ana.20529 · Cited by 369
Baekkeskov, S., Aanstoot, H.-J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Oleson, H., & Camilli, P. D. (1990) · Nature · doi:10.1038/347782a0 · Cited by 352
The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome
Dalakas, M. C., Fujii, M., Li, M., & McElroy, B. (2000) · Neurology · doi:10.1212/wnl.55.10.1531 · Cited by 331
Kim, J., Chung, J. I., Yoon, P. H., Kim, D. I., Chung, T., Kim, E., & Jeong, E. (2001) · PubMed Central · Cited by 314
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy
Peltola, J., Kulmala, P., Isojärvi, J., Saiz, A., Latvala, K., Palmio, J., Savola, K., Knip, M., Keränen, T., & Graus, F. (2000) · Neurology · doi:10.1212/wnl.55.1.46 · Cited by 296
Self-citationEffects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases
Manto, M., Laute, M., Aguera, M., Rogemond, V., Pandolfo, M., & Honnorat, J. (2007) · Annals of Neurology · doi:10.1002/ana.21123 · Cited by 249
Serum antibodies in epilepsy and seizure-associated disorders
McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., & Lang, B. (2005) · Neurology · doi:10.1212/01.wnl.0000187129.66353.13 · Cited by 231
Glutamic Acid Decarboxylase Autoimmunity With Brainstem, Extrapyramidal, and Spinal Cord Dysfunction
Pittock, S. J., Yoshikawa, H., Ahlskog, J. E., Tisch, S. H., Benarroch, E. E., Kryzer, T. J., & Lennon, V. A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1207 · Cited by 231
Stiff person syndrome: Quantification, specificity, and intrathecal synthesis of GAD 65 antibodies
Dalakas, M. C., Li, M., Fujii, M., & Jacobowitz, D. M. (2001) · Neurology · doi:10.1212/wnl.57.5.780 · Cited by 215
Autoantibody Profiles and Neurological Correlations of Thymoma
Vernino, S., & Lennon, V. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0735 · Cited by 202
Kim, J., Namchuk, M., Bugawan, T., Fu, Q., Jaffe, M., Shi, Y., Aanstoot, H. J., Turck, C. W., Erlich, H., Lennon, V, et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.595 · Cited by 192
Solimena, M., & De Camilli, P. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90044-u · Cited by 183
Walikonis, J., & Lennon, V. A. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.12.1161 · Cited by 164
Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases
Meinck, H. ‐. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.1.100 · Cited by 143
Antibodies to voltage-gated potassium and calcium channels in epilepsy
Majoie, M., de Baets, M., Renier, W. O., Lang, B., & Vincent, A. C. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.06.003 · Cited by 140
Schmidli, R. S., Colman, P. G., & Bonifacio, E. E. (1995) · Diabetes · doi:10.2337/diab.44.6.636 · Cited by 131
Daw, K., Ujihara, N., Atkinson, M. A., & Powers, A. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.818 · Cited by 126
Serisier, D. (1995) · Journal of Clinical Neuroscience · doi:10.1016/0967-5868(95)90015-2 · Cited by 119
Murinson, B. B. (2004) · The Neurologist · doi:10.1097/01.nrl.0000126587.37087.1a · Cited by 113
Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy
Nemni, R., Braghi, S., Sora, M. G. N., Lampasona, V., Bonifacio, E. E., Comi, G. P., & Canal, N. (1994) · Annals of Neurology · doi:10.1002/ana.410360419 · Cited by 90
Stiff-man syndrome in a woman with breast cancer
Rosin, L., DeCamilli, P., Butler, M. H., Solimena, M., Schmitt, H., Morgenthaler, N. G., & Meinck, H. ‐. (1998) · Neurology · doi:10.1212/wnl.50.1.94 · Cited by 86
Stiff‐leg syndrome: A focal form of stiff‐man syndrome
Saiz, A., Graus, F., Valldeoriola, F., Valls‐Solé, J., & TOLOSA, E. S. (1998) · Annals of Neurology · doi:10.1002/ana.410430322 · Cited by 75
Self-citationEpilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies
Vulliémoz, S., Vanini, G., Truffert, A., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.089268 · Cited by 72
Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study
Kwan, P., Sills, G. J., Kelly, K., Butler, E., & Brodie, M. J. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00180-7 · Cited by 67
Olson, J., Olson, D. M., Sandborg, C. I., Alexander, S. R., & Buckingham, B. A. (2002) · PEDIATRICS · doi:10.1542/peds.109.3.e50 · Cited by 54
Vianello, M., Keir, G., Giometto, B., Betterle, C., Tavolato, B. F., & Thompson, E. J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00933.x · Cited by 48
Koriyama, N., Kakei, M., Yaekura, K., Okui, H., Yamashita, T., Nishimura, H., Matsushita, S., & Tei, C. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023513 · Cited by 45
Effect of Glucagon on Glucose Production, Lipolysis, and Gluconeogenesis in Familial Hyperinsulinism
Cederblad, F., Ewald, U., & Gustafsson, J. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023242 · Cited by 38
Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt–Jakob disease
Chang, C.-C., Eggers, S. D. Z., Johnson, J. K., Haman, A., Miller, B. L., & Geschwind, M. D. (2006) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2006.01.009 · Cited by 31
Kim, J., Chung, E. J., Kim, J., et al. (2006) · Movement Disorders · doi:10.1002/mds.21041 · Cited by 20
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationDalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Self-citationAutoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Carvajal-González, A., Leite, M. I., Waters, P., Woodhall, M., Coutinho, E., Balint, B., Lang, B., Pettingill, P., Carr, A., Sheerin, U.-M., et al. (2014) · Brain · doi:10.1093/brain/awu142 · Cited by 532
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
Self-citation
Metadata
- Authors
- Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08-07
- Volume
- 131
- Issue
- 10
- Pages
- 2553-2563
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2078990452
- Cited by
- 623
- References
- 36
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.